%20(1).png)
Mission
Neurometry was built from lived experience. A grandmother whose first symptom of dementia was losing her second language — mistaken for shyness by a family who assumed she was simply quiet. A founder whose own cognitive differences went undiagnosed for years, until the right clinical framework was finally applied. A shareholder who, three years after stroke, pieced together her own recovery pattern through online communities — because no clinical infrastructure followed her home after discharge.
These are not edge cases. They are the everyday reality of cognitive illness — poorly measured, frequently misread, and largely invisible beyond the clinic door.
Neurometry exists to change that. We build longitudinal, multimodal cognitive measurement infrastructure for NHS clinical pathways — and put the same data in the hands of patients, carers, and families. Because the gap doesn't close at discharge. It widens.
Leadership Team
-2.jpg)
Omair Ahmed, CEO
A biotech and finance entrepreneur with a strong foundation in statistics, he has contributed to multiple MedTech and Biotech ventures across cardiology, immunology, pain management, and neuro-inflammatory applications. His experience includes leadership roles at AbCelex Technology and the spinoff of Orpheus Medica, as well as advisory work for Kondor Pharma.
Previously, he spent 12 years in derivatives trading and portfolio management at RBC Royal Bank and BMO Capital Markets, later founding Taunton Capital LLP, a systematic trading fund. His work was recognized at the World Economic Forum’s COVID-19 Response Challenge in 2020.
He holds an MSc in Quantitative Finance from London Business School and an Honours BA in Econometrics and Theology from the University of Toronto, and is an active member of the Milken Institute and FasterCures. His interdisciplinary background informs his leadership at Neurometry.
Dr Prabitha Urwyler, Biomedical Scientist
She is a distinguished clinical researcher with a diverse 13-year background in software engineering within the Tech and Media sectors. Her journey began with a PhD focused on the fabrication, characterization, and application of disposable microcantilevers for biomedical purposes. She continued her postdoctoral research at the Biomaterials Science Centre, University of Basel,followed by the University Hospital of Psychiatry in Bern. She served as a researcher and deputy group head at the Gerontechnology and Rehabilitation Group, ARTORG Center at the University of Bern, and as a scientific officer and program manager at Innosuisse, the Swiss Innovation Agency. Her extensive research career spans nanotechnology, biosensors, biomaterials, implant surface characterization, micro/nanofabrication, neuroscience, psychiatry, neurodegenerative diseases, gerontechnology, ambient assisted living, telehealth, and rehabilitation. She holds a Bachelor of Technology in Computer Science & Engineering from Mangalore University, an MSc in Biomedical Engineering from the University of Bern, a PhD in Biomedical Engineering from the University of Basel and the Paul Scherrer Institute, and a Venia Docendi (PD) from the University of Bern. Dr. Urwyler’s interdisciplinary expertise and passion for improving quality of life through innovative biomedical solutions make her an invaluable leader at Neurometry. make this brief too
Dr Christoph Mueller
Dr Christoph Mueller is a Reader in Ageing and Mental Health Data Science at King’s College London and a Consultant Old Age Psychiatrist within the NHS. He is in the same clinical team with Dr. Latha Velayudhan His research focuses on dementia and mental health in later life, using large-scale electronic health records and advanced clinical informatics. He leads work on disease progression, treatment outcomes, and digital interventions, and actively bridges academic research with clinical practice and public engagement.
Dr Rohit Shankar
Dr Rohit Shankar is Professor of Neuropsychiatry at the University of Plymouth and an NHS Consultant Neuropsychiatrist, with honorary appointments at Exeter Medical School. An MBE and Royal College of Psychiatrists Fellow, he leads internationally recognised research in epilepsy, SUDEP, and intellectual disability, and has authored 300+ peer-reviewed publications. (edited)
Dr Latha Velayudhan
Dr Latha Velayudhan is a Clinical Reader in Ageing and Dementia at King’s College London (IoPPN) and a Consultant Psychiatrist at South London & Maudsley NHS Foundation Trust, where she leads the Lewisham Memory Service. Her research focuses on neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease, with interests in neuropsychiatric symptoms, biomarkers, and clinical trials.
Clinical Partners
Our Investors Are Advisors
Dr Michelle Tempest, Clinical Advisor
Michelle, a Senior Partner at Candesic since 2004, over a decade of experience as a front-line doctor. As a Board member, she has driven global growth by improving clinical outcomes and financial performance. An author editor, she graduated from Cambridge University, holds a legal master's degree, is a member of Cambridge Angels, and mentors-ups on the digital council at the Society of Medicine.
An entrepreneurial CEO with 25+ years of experience in B2B and B2C online gaming and sports betting. He has led teams across all business functions and launched over 50 brands globally. His background includes securing funding and achieving exits through sales and IPOs. as a manufacturing engineer, he earned an MBA from London Business School, transitioned to entrepreneurship, and now runs a consulting practice while mentoring early-stage founders at the school.
Joe Baddoura, US Healthcare Advisor
Accomplished senior healthcare executive with extensive experience at General Psychiatry Hospital, specializing in strategy, operations finance, and growth. A proven leader in service expansion, enhancing patient access, and optimizing organizational performance. Expertise in revenue optimization mergers and acquisitions, and cultivating high-performing teams within complex healthcare environments.